Alvotech And Teva Claim First US Golimumab Filing

FDA Submission For Limited-Competition Simponi Biosimilar Follows EMA Acceptance

 
• By Dave Wallace
  
The FDA has accepted the Simponi rival for review (Shutterstock)

More from Biosimilars

More from Generics Bulletin